-+ 0.00%
-+ 0.00%
-+ 0.00%

Rigel Pharmaceuticals Affirms FY2025 Sales Guidance of $200.00M-$210.00M vs $228.79M Est

Benzinga·05/06/2025 21:44:07
Listen to the news
Rigel Pharmaceuticals (NASDAQ:RIGL) affirms FY2025 sales outlook from $200.00 million-$210.00 million to $200.00 million-$210.00 million vs $228.79 million estimate.